Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

229
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Prophylactic Insulin in Surgical Patients without Diabetes: A Pilot Randomized, Controlled Trial.

Annals of surgery·2026
Same author

Barriers and facilitators to neurodevelopmental follow-up among at-risk newborns across Washington State.

Research square·2026
Same author

Spinal Manipulation and Clinician-Supported Self-Management for Preventing Chronic Low Back Pain Impact: The PACBACK Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

The importance of iron in neonatal and infant nutrition.

Seminars in perinatology·2026
Same author

Interhospital Transport Characteristics for Neonates With Congenital Diaphragmatic Hernia.

Air medical journal·2026
Same author

Support for Transgender and Nonbinary Individuals Seeking Vaginoplasty (STRIVE) study: protocol for a national randomised pragmatic trial.

BMJ open·2026

Related Experiment Video

Updated: Jan 8, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K

Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment

Sandra E Juul1,2, Bryan A Comstock3, Dennis E Mayock4

  • 1Department of Pediatrics, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. sjuul@uw.edu.

Trials
|December 23, 2025
PubMed
Summary

This Phase II trial investigates darbepoetin plus intravenous iron for preterm infants to reduce anemia and transfusions. The study assesses safety, efficacy, and neurodevelopmental outcomes up to two years corrected age.

Keywords:
AnemiaDarbepoetinIV ironIron deficiencyPrematurityRed blood cell transfusions

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Developmental Pediatrics

Background:

  • Preterm infants face high risks of anemia, iron deficiency, and transfusions, impacting neurodevelopment.
  • Erythropoietic-stimulating agents and intravenous iron are potential interventions.

Purpose of the Study:

  • To evaluate the safety and efficacy of darbepoetin combined with slow-release intravenous iron (ferumoxytol or low-molecular-weight iron dextran) in preterm infants.
  • To determine the optimal iron preparation and dosage for maintaining iron sufficiency and reducing transfusions.
  • To assess the impact of these treatments on the gut microbiome and neurodevelopment.

Main Methods:

  • A randomized controlled Phase II trial involving 120 preterm infants (24-0/7 to 31-6/7 weeks gestation).
  • Infants were randomized into five groups: oral iron (standard care) or weekly darbepoetin with varying doses of ferumoxytol or low-molecular-weight iron dextran.
  • Outcomes include ferritin levels, hematologic assessments, drug safety, microbiome analysis, and neurodevelopmental testing up to 2 years corrected age.

Main Results:

  • Primary outcome is ferritin level at 34-36 weeks postmenstrual age.
  • Secondary outcomes include transfusion rates, safety, microbiome diversity, and neurodevelopmental trajectories.
  • The study is ongoing, and results are pending.

Conclusions:

  • This trial will provide crucial data on the safety and effectiveness of novel iron supplementation strategies in preterm infants.
  • Findings will inform clinical practice regarding anemia management and its long-term effects on neurodevelopment.
  • The study will elucidate the relationship between intravenous iron, gut microbiome, and neurodevelopmental outcomes.